Nexeon MedSystems, Inc. closed at $5.95 in the latest trading session, marking no change from the prior day. This change was narrower than the S&P 500's daily loss of 2.06%. Elsewhere, the Dow lost 1.81%, while the tech-heavy Nasdaq lost 2.99%.
Wall Street will be looking for positivity from NXNN as it approaches its next earnings report date. This is expected to be April 4, 2019. On that day, NXNN is projected to report earnings of -$0.82 per share, which would represent year-over-year growth of 41.43%. Our most recent consensus estimate is calling for quarterly revenue of $1.84 million, down 15.05% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$2.37 per share and revenue of $9.50 million. These totals would mark changes of +34.89% and +187.68%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for NXNN. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 50% lower. NXNN is holding a Zacks Rank of #3 (Hold) right now.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 63, putting it in the top 25% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Image: Bigstock
Nexeon MedSystems, Inc. (NXNN) Flat As Market Sinks: What You Should Know
Nexeon MedSystems, Inc. closed at $5.95 in the latest trading session, marking no change from the prior day. This change was narrower than the S&P 500's daily loss of 2.06%. Elsewhere, the Dow lost 1.81%, while the tech-heavy Nasdaq lost 2.99%.
Wall Street will be looking for positivity from NXNN as it approaches its next earnings report date. This is expected to be April 4, 2019. On that day, NXNN is projected to report earnings of -$0.82 per share, which would represent year-over-year growth of 41.43%. Our most recent consensus estimate is calling for quarterly revenue of $1.84 million, down 15.05% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$2.37 per share and revenue of $9.50 million. These totals would mark changes of +34.89% and +187.68%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for NXNN. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 50% lower. NXNN is holding a Zacks Rank of #3 (Hold) right now.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 63, putting it in the top 25% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.